EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Alternative magnetic field exposure suppresses tumor growth via metabolic reprogramming

Taisuke Akimoto, Md Rafikul Islam, Akane Nagasako, Kazuhito Kishi, Rina Nakakaji, Makoto Ohtake, Hisashi Hasumi iD, Takashi Yamaguchi, Shigeki Yamada, Tetsuya Yamamoto, Yoshihiro Ishikawa, Masanari Umemura iD

Cancer Science · 2024

DOI: 10.1111/cas.16243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Taisuke Akimoto und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan. Hauptthemen laut MEDLINE: Brain Neoplasms, Cell Proliferation, Glioblastoma, Magnetic Field Therapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Science and Technology Agency, Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Application of physical forces, ranging from ultrasound to electric fields, is recommended in various clinical practice guidelines, including those for treating cancers and bone fractures. However, the mechanistic details of such treatments are often inadequately understood, primarily due to the absence of comprehensive study models. In this study, we demonstrate that an alternating magnetic field (AMF) inherently possesses a direct anti‐cancer effect by enhancing oxidative phosphorylation (OXPHOS) and thereby inducing metabolic reprogramming. We observed that the proliferation of human glioblastoma multiforme (GBM) cells (U87 and LN229) was inhibited upon exposure to AMF within a specific narrow frequency range, including around 227 kHz. In contrast, this exposure did not affect normal human astrocytes (NHA). Additionally, in mouse models implanted with human GBM cells in the brain, daily exposure to AMF for 30 min over 21 days significantly suppressed tumor growth and prolonged overall survival. This effect was associated with heightened reactive oxygen species (ROS) production and increased manganese superoxide dismutase (MnSOD) expression. The anti‐cancer efficacy of AMF was diminished by either a mitochondrial complex IV inhibitor or a ROS scavenger. Along with these observations, there was a decrease in the extracellular acidification rate (ECAR) and an increase in the oxygen consumption rate (OCR). This suggests that AMF‐induced metabolic reprogramming occurs in GBM cells but not in normal cells. Our results suggest that AMF exposure may offer a straightforward strategy to inhibit cancer cell growth by leveraging oxidative stress through metabolic reprogramming.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsCell ProliferationGlioblastomaMagnetic Field TherapyMetabolic ReprogrammingOxidative PhosphorylationReactive Oxygen SpeciesAnimalsHumansMiceAstrocytesCell Line, TumorMagnetic FieldsMitochondriaOxygen ConsumptionSuperoxide DismutaseXenograft Model Antitumor Assays

Stichwörter der Autor:innen

alternating magnetic field (AMF)glioblastoma multiforme (GBM)metabolic reprogrammingmitochondriaoxidative phosphorylation (OXPHOS)reactive oxygen species (ROS)

Substanzen

Reactive Oxygen SpeciesSuperoxide Dismutase

Autor:innen und Institutionen

  • Department of Neurosurgery, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
  • Department of Biochemistry and Molecular Biology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences (UAMS), Little Rock, Arkansas, USA.
  • Cardiovascular Research Institute, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
  • Ricoh Company, Ltd., Ohta-ku, Tokyo, Japan.
  • Department of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
  • Department of Materials System Science, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.

ORCID-Profile: Hisashi Hasumi, Masanari Umemura

Förderung

  • Japan Science and Technology Agency
  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • Ricoh Co., Ltd.

Zitieren

APA

Akimoto, T., Islam, M. R., Nagasako, A., Kishi, K., Nakakaji, R., Ohtake, M., Hasumi, H., Yamaguchi, T., Yamada, S., Yamamoto, T., Ishikawa, Y., & Umemura, M. (2024). Alternative magnetic field exposure suppresses tumor growth via metabolic reprogramming. Cancer Science. https://doi.org/10.1111/cas.16243

Vancouver

Akimoto T, Islam MR, Nagasako A, Kishi K, Nakakaji R, Ohtake M, et al. Alternative magnetic field exposure suppresses tumor growth via metabolic reprogramming. Cancer Science. 2024. doi:10.1111/cas.16243

BibTeX
@article{Akimoto2024,
  author = {Akimoto, Taisuke and Islam, Md Rafikul and Nagasako, Akane and Kishi, Kazuhito and Nakakaji, Rina and Ohtake, Makoto and Hasumi, Hisashi and Yamaguchi, Takashi and Yamada, Shigeki and Yamamoto, Tetsuya and Ishikawa, Yoshihiro and Umemura, Masanari},
  title = {Alternative magnetic field exposure suppresses tumor growth via metabolic reprogramming},
  journal = {Cancer Science},
  year = {2024},
  doi = {10.1111/cas.16243}
}
Kostenlos starten →